Targets and Indicators Monitoring and Evaluation

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

A Guide to Monitoring and Evaluating HIV/AIDS Care and Support.
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
“Writing our own narratives” The Global Advocacy Agenda for Young People Living with HIV.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
Unit 10. Monitoring and evaluation
Guidance on TB infection control Fabio Scano Stop TB, WHO.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Monitoring &Evaluation System in Health Program. Brief overview of NACP Reporting units and quality aspects Data sets Learning/ Analysis of the data sets.
October 20, 2015 UNAIDS Monitoring and Evaluation of HIV Programs for MSM Linking data to Program Planning, Implementation, and Advocacy UNAIDS/S.NOORANI.
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
Implementing the revised TB/HIV indicators and data harmonisation at country level Christian Gunneberg MO WHO Planning workshop to accelerate the implementation.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
Haileyesus Getahun Stop TB Department WHO Re-conceptualizing ICF and IPT: global progress to date 14 th Core Group Meeting of the TB/HIV Working Group,
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
Arguments for and against the inclusion of a National Policy Framework in the Children’s Bill Portfolio Committee briefing Department of Social Development.
The Multi-Sectoral Provincial Strategic Plan for HIV & AIDS, STIs & TB of KwaZulu-Natal Presentation to PEPFAR all partners meeting Monday 28.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Collaborative TB/HIV Activities. Collaborative TB/HIV activities A.To establish the mechanisms for collaboration B.To decrease the burden of TB in PLWHA.
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
ICE MEETING 2001 EUROPEAN UNION GROUP AIM FORUM FOR PROMOTING DISCUSSION BETWEEN ICE AND EU ON AREAS OF MUTUAL INTEREST.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
How to move forward with M&E of TB/HIV? TB/HIV Core Group New York City April 17, 2008 Riitta Dlodlo.
Session VII: Formulation of Monitoring and Evaluation Plan
Overview of guidance/frameworks
Preliminary Recommendations for Limpopo Province
Monitoring and Evaluation Frameworks
Effective HIV & SRH Responses among Key Populations in Myanmar
UNESCO: More than Education!
Arguments for and against the inclusion of a
Facilitator Notes: Explain that this presentation provides a brief introduction to the global framework of Positive Health, Dignity, and Prevention (PHDP)
PROGRESS BUT MORE NEEDED!
8-9 August 2009, Bali, Indonesia
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
World Health Organization
Sunday, 22 July, 07:30-20:00 Room Elicium 1, RAI Amsterdam
Sustainable management of E-waste
Collecting High-Quality Data
Progress in Implementation of TB/HIV Collaborative activities
WHO global policy development process for TB/HIV
Enablers for nationwide expansion of collaborative TB/HIV activities
Screening and diagnosing TB in PLHIV: Challenges and ways forward
SRH & HIV Linkages Agenda
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
Conclusions and recommendations – first draft
Interim TB/HIV Document
Module 8 ACTION PLANS.
Project collaborators’ names
M&E Frameworks! Yesterday we reviewed the basics about ACSM and introduced some common terms that we will be using for the rest of this week. Today we.
Promoting Adoption and Implementation of WHO recommendations
Background to ProTEST and its Role in TB/HIV Agenda-setting
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
The ProTEST Projects:Achievements so far
Presentation for Second Meeting of the Global TB/HIV Working Group
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
VISION I started with this and will end with it because it is important to know where we want to go. It sets the direction to take. IF YOU DON’T KNOW WHERE.
Surveillance, Monitoring and Evaluation Working Group
Routine Counselling and HIV testing (CT) for TB patients in Malawi: Rhehab Chimzizi TB-HIV Programme officer National TB Control Programme-Malawi.
33rd IUATLD World Conference on Lung Health
TB-HIV/AIDS Co-Infection Coordination among Programs
Gender Training Workshop Name of Institution Place Date
Presentation transcript:

Targets and Indicators Monitoring and Evaluation Alasdair Reid

Outline Why M&E? Simple guide to M&E of collaborative TB/HIV programme activities Developing Indicators and targets

WHY M&E? Ensuring quality Programme management Promote a learning culture Accountability Attract resources

Guide to M&E Strengthen M&E systems at all levels Uniformity Avoid duplication

M&E for TB/HIV Develop guidelines for M&E Identify minimum core indicators and targets Develop reporting tools for M&E at all levels Recommend the frequency of reporting Identify minimum resource requirements Consider additional indicators for special circumstances or for evaluation of new interventions

Who for? National TB, HIV and TB/HIV programme managers and coordinators Service deliverers Funders

Guide to M&E Outline draft Introduction and background Brief overview of M&E Overview of collaborative TB/HIV programme activities Framework for TB/HIV M&E Operationalisation Indicators & targets

Indicators and targets Aim – Objectives – Activities – Indicators – Targets

Indicators AIM: To decrease the burden of TB in populations where HIV may fuel the TB epidemic: interventions against TB (DOTS strategy, ICF and TB preventive treatment) interventions against HIV (and therefore indirectly against TB), e.g. condoms, STI treatment, HAART

Objectives Project proposals Guidelines for implementing collaborative TB and HIV programme activities

Activity areas Background/Baseline data Strengthening health services/systems HIV counselling and testing Strengthening DOTS and ICF Strengthening HIV prevention Care and support for people with TB/HIV Costs and cost-effectiveness Stigma?

Indicator fields Indicator Series and Title Brief Description Core/Desirable/Optional Definition: numerator and denominator, what it measures Strengths and limitations Data source Resource requirements

Indicator fields Level Periodicity Indicator source Targets

Indicators Simple Minimal resources Easy to collect Useful to health service providers Rapid feedback Avoid cohort analysis unless necessary

Indicators